Flu Shots for Your Patients Aged ≥65 Years: 2 Questions

ACIP Supports Lowering Age for Pneumococcal Vaccination to 50 from 65 Years

CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.

ACIP Supports Lowering Age for Pneumococcal Vaccination to 50 Years / image credit ©CDC

FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions

The expanded recommendation includes shots from Merck (PCV21) and Pfizer (PCV20), and could be a "practice-changing milestone," one executive said.

FDA Updates Flublok Label with Safety Data for Pregnant Individuals

Pfizer announced the FDA approval on October 22 that makes Abrysvo now the RSV immunization with the broadest indication for adults, the company said.

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults

The safety data used to update the Flublok label is from a study of more than 48 000 pregnant women across multiple flu seasons, according to Sanofi.

October 21st 2024

IDWeek 2024: Novavax Reports Positive Data for Novel Influenza and Flu-COVID-19 Combination Vaccines

IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data.

October 18th 2024

ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals

IDWeek2024: The nanoparticle influenza vaccine and combination flu-Covid-19 shot produced immunogenicity comparable to or higher than comparator vaccines.

Related Content

ACIP Supports Lowering Age for Pneumococcal Vaccination to 50 from 65 Years

CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.

FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions

The expanded recommendation includes shots from Merck (PCV21) and Pfizer (PCV20), and could be a "practice-changing milestone," one executive said.

FDA Updates Flublok Label with Safety Data for Pregnant Individuals

Pfizer announced the FDA approval on October 22 that makes Abrysvo now the RSV immunization with the broadest indication for adults, the company said.

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults

The safety data used to update the Flublok label is from a study of more than 48 000 pregnant women across multiple flu seasons, according to Sanofi.

October 21st 2024

IDWeek 2024: Novavax Reports Positive Data for Novel Influenza and Flu-COVID-19 Combination Vaccines

IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data.

October 18th 2024